Caixin
May 03, 2018 07:29 PM
BUSINESS & TECH

Merck’s HPV Vaccine Wins Lightning-Fast Approval

Gardasil 9 is available in more than 70 countries and regions. Photo: VCG
Gardasil 9 is available in more than 70 countries and regions. Photo: VCG

U.S. drugmaker Merck & Co. Inc. has received speedy approval to launch its most effective vaccine against the human papillomavirus (HPV) on the Chinese mainland market.

The approval after three years — lightning-quick in pharmaceutical regulatory terms — indicates that China’s drug regulator has recognized the urgent demand for the vaccine, which protects against a major cause of the second-most common type of cancer in the country among women.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
Copyright © 2017 Caixin Global Limited. All Rights Reserved.